Esomeprazole + Levosulpiride Pellets

Anti-Ulcerant (PPIs) • Pellets

Bilayered pellets combining acid suppression with prokinetic support, engineered to minimise segregation in capsule fills.

40 mg + 75 mg
  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Esomeprazole is a proton pump inhibitor, while Levosulpiride is used as a prokinetic component in gastrointestinal formulations. Rraynex focuses on controlled pellet density, particle-size distribution, API isolation, and formulation-specific dissolution to support capsule, sachet, and other multiparticulate dosage forms.

Key characteristics

  • Dual-layer formulation approach.
  • Controlled API isolation and barrier protection.
  • Density-matched pellets to minimize segregation.
  • Suitable for capsule and multiparticulate systems.
  • Technical support for dissolution, stability, excipient compatibility, and regulatory documentation.

Product specifications

Product
Esomeprazole + Levosulpiride Pellets
Form
Pellets
Therapeutic category
Anti-Ulcerant (PPIs)
Strength
40 mg + 75 mg
Grade
IP / BP / USP / EP
Pack size
25/50 kg
Site certifications
WHO-GMP, ISO 9001, ISO 14001

Detailed specifications, COA and technical documentation are shared on request.

Supply and enquiries

Rraynex supplies Esomeprazole + Levosulpiride Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.

Send product enquiry Browse all pellets Manufacturing capabilities

Other Esomeprazole products from Rraynex

Frequently asked questions

Enquire Now